Malignant Tumors of the Conjunctival Epithelium Treatments

Malignant Tumors of the Conjunctival Epithelium Treatments - Malignant Tumors of the Conjunctival Epithelium Treatments

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007447

Enrollment

Registered

2012-03-05

Start date

2005-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

conjunctival dysplasia conjunctival carcinoma in situ conjunctival squamous cell carcinoma

Interventions

control1 topical 0.04%MMC(4 doses/day) for 1week followed by 1week without treatment.continue it until a tumor disappears.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patient who had malignant tumors of the conjunctival epithelium

Exclusion criteria

Exclusion criteria: not

Design outcomes

Primary

Measure	Time frame
Recurrence rate during an observation period	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026